Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making DOI
Renumathy Dhanasekaran, Hiroyuki Suzuki, L Lemaître

et al.

Hepatology, Journal Year: 2023, Volume and Issue: unknown

Published: June 10, 2023

Liver cancer, primarily HCC, exhibits highly heterogeneous histological and molecular aberrations across tumors within individual tumor nodules. Such intertumor intratumor heterogeneities may lead to diversity in the natural history of disease progression various clinical disparities patients. Recently developed multimodality, single-cell, spatial omics profiling technologies have enabled interrogation intertumor/intratumor heterogeneity cancer cells immune microenvironment. These features influence efficacy emerging therapies targeting novel pathways, some which had been deemed undruggable. Thus, comprehensive characterization at levels facilitate discovery biomarkers that enable personalized rational treatment decisions, optimize while minimizing risk adverse effects. companion will also refine HCC algorithms stages for cost-effective patient management by optimizing allocation limited medical resources. Despite this promise, complexity ever-expanding inventory therapeutic agents regimens made evaluation translation increasingly challenging. To address issue, trial designs proposed incorporated into recent studies. In review, we discuss latest findings landscape their potential utility as biomarkers, framework application predictive/prognostic ongoing biomarker-guided trials. new developments revolutionize care substantially impact still dismal mortality.

Language: Английский

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution DOI Creative Commons

Wenhui Yang,

Shimao Liu,

Mengyun Mao

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2024, Volume and Issue: 43(1)

Published: Feb. 2, 2024

Abstract Tumor-infiltrating T cells recognize, attack, and clear tumor cells, playing a central role in antitumor immune response. However, certain can impair this response help escape. Therefore, exploring the factors that influence T-cell infiltration is crucial to understand immunity improve therapeutic effect of cancer immunotherapy. The use single-cell RNA sequencing (scRNA-seq) allows high-resolution analysis precise composition with different phenotypes other microenvironmental factors, including non-immune stromal related molecules microenvironment various types. In review, we summarized research progress on crosstalk cytokines during using scRNA-seq provide insights into mechanisms regulating contribute new perspectives

Language: Английский

Citations

27

Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma DOI Creative Commons
Ao Chen, Xin Zhang, Qingyang Zhang

et al.

Gut, Journal Year: 2024, Volume and Issue: 74(1), P. 90 - 102

Published: June 5, 2024

Fat mass and obesity-associated protein (FTO), an eraser of

Language: Английский

Citations

25

Role of LMO7 in cancer (Review) DOI
Qun Zeng, Tingting Jiang, Jing Wang

et al.

Oncology Reports, Journal Year: 2024, Volume and Issue: 52(3)

Published: July 11, 2024

Language: Английский

Citations

17

Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery DOI
Curtis Dobrowolski, Kalina Paunovska, Elisa Schrader Echeverri

et al.

Nature Nanotechnology, Journal Year: 2022, Volume and Issue: 17(8), P. 871 - 879

Published: June 30, 2022

Language: Английский

Citations

60

Untangling the web of intratumour heterogeneity DOI
Zheqi Li, Marco Seehawer, Kornélia Polyák

et al.

Nature Cell Biology, Journal Year: 2022, Volume and Issue: 24(8), P. 1192 - 1201

Published: Aug. 1, 2022

Language: Английский

Citations

58

Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing DOI
Xinyue Li, Yue Shen, Li Zhang

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2022, Volume and Issue: 1877(3), P. 188720 - 188720

Published: March 15, 2022

Language: Английский

Citations

53

T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis DOI
Pierluigi Ramadori,

Shing Kam,

Mathias Heikenwälder

et al.

Hepatology, Journal Year: 2022, Volume and Issue: 75(4), P. 1038 - 1049

Published: Jan. 13, 2022

Abstract In association with the pandemic spreading of obesity and metabolic syndrome, prevalence NAFLD‐related HCC is increasing almost exponentially. recent years, many underlining multifactorial causes NAFLD have been identified, cellular mechanisms sustaining disease development dissected up to single‐cell level. However, there still an urgent need provide clinicians more therapeutic targets, particular attention on NAFLD‐induced HCC, where immune checkpoint inhibitors do not work as efficiently. Whereas much effort has invested in elucidating role innate response hepatic microenvironment, only past decade novel critical roles unraveled for T cells driving chronic inflammation toward HCC. The microenvironment interact recreate a tumor‐promoting immune‐suppressive terrain, responsible resistance anticancer therapy. this article, we will review specific functions several T‐cell populations involved NAFLD‐driven We illustrate crosstalk other cells, regulatory networks or stimulatory effects these interactions, influencing cell functionality. Finally, present pros cons current strategies against delineate possible approaches future.

Language: Английский

Citations

50

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation DOI
Haonan Li, Qiang Luo, Hu Zhang

et al.

Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 52(1), P. 47 - 96

Published: Nov. 25, 2022

This review overviews the landscape of nanomedicine-aided cancer radio-immunotherapy in a “from bench to clinic” manner.

Language: Английский

Citations

47

Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer DOI Creative Commons
Handong Sun, Lishen Zhang, Zhong Lin Wang

et al.

Nature Communications, Journal Year: 2023, Volume and Issue: 14(1)

Published: Sept. 11, 2023

Male breast cancer (MBC) is a rare but aggressive malignancy with cellular and immunological characteristics that remain unclear. Here, we perform transcriptomic analysis for 111,038 single cells from tumor tissues of six MBC thirteen female (FBC) patients. We find has significantly lower infiltration T relative to FBC. Metastasis-related programs are more active in MBC. The activated fatty acid metabolism involved FASN related cell metastasis low immune show activation p38 MAPK lipid oxidation pathways, indicating dysfunctional state. In contrast, FBC exhibit higher expression cytotoxic markers pathways mediated by immune-modulatory cytokines. Moreover, identify the inhibitory interactions between Our study provides important information understanding immunology

Language: Английский

Citations

29

A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes DOI Creative Commons
Shanshan Yang, Chengyu Liu, Mengmeng Jiang

et al.

Protein & Cell, Journal Year: 2023, Volume and Issue: 15(2), P. 98 - 120

Published: June 28, 2023

Aging increases the risk of liver diseases and systemic susceptibility to aging-related diseases. However, cell type-specific changes underlying mechanism aging in higher vertebrates remain incompletely characterized. Here, we constructed first single-nucleus transcriptomic landscape primate aging, which resolved gene expression fluctuation hepatocytes across three zonations detected aberrant cell-cell interactions between niche cells. Upon in-depth dissection this rich dataset, identified impaired lipid metabolism upregulation chronic inflammation-related genes prominently associated with declined functions during aging. In particular, hyperactivated sterol regulatory element-binding protein (SREBP) signaling was a hallmark aged liver, consequently, forced activation SREBP2 human primary recapitulated vivo phenotypes, manifesting as detoxification accelerated cellular senescence. This study expands our knowledge informs development diagnostics therapeutic interventions for

Language: Английский

Citations

28